DRUG PIPELINE

Our plan is to use our pipeline of gene therapies that serve a population of patients who suffer from rare diseases with high unmet medical needs. Our platform technologies and clinical program bridges the gap between innovation and a potential cure. We are creating an solid AAV gene therapy pipeline, with each formulation targeting the underlying pathology of the specific indication. Our lead candidates include . treatments for Dravet Syndrome and limpic orbital